Inicio
Markets
Charts & Ideas
Algo
Noticias
Store
Corredores
Descargar
Calendario económico
Señales Comerciales
WebTerminal
Pulse
/
para buscar: @user, $symbol, ...
Buscar
Entrada
Crear una cuenta
Español
English
Русский
中文
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
XTLB
#8920
XTL Biopharmaceuticals Ltd. American Depositary Shares
0.600
0
USD
-4.76%
Sector:
Atención Sanitaria
Básica:
USD
Profit Currency:
USD
Rango diario
Rango anual
Cambio diario
-4.76%
Monthly Change
-33.18%
6 month change
-33.18%
Cambio anual
-33.18%
Cierres anteriores
0.630
0
Open
0.600
0
Bid
0.600
0
Ask
0.603
0
Low
0.600
0
High
0.600
0
Volumen
1
Markets
Acciones
Atención Sanitaria
XTLB
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
Q4, 24
TTM
Key stats
Total common shares outstanding
220.35 M
629.03 M
Valuation ratios
Enterprise value
446.38 M
1.13 B
Price to earnings ratio
—
—
Price to sales ratio
—
—
Price to cash flow ratio
—
—
Price to book ratio
—
—
Enterprise value to EBITDA ratio
—
—
Profitability ratios
Return on assets %
—
—
Return on equity %
—
—
Return on invested capital %
—
—
Gross margin %
—
—
Operating margin %
—
—
EBITDA margin %
—
—
Net margin %
—
—
Liquidity ratios
Quick ratio
—
—
Current ratio
—
—
Inventory turnover
—
—
Asset turnover
—
—
Solvency ratios
Debt to assets ratio
—
—
Debt to equity ratio
—
—
Long term debt to total assets ratio
—
—
Long term debt to total equity ratio
—
—
Per share metrics
Operating cash flow per share
—
—
EBIT per share
—
—
EBITDA per share
—
—
Total debt per share
—
—
Cash per share
—
—
Net current asset value per share
—
—
Tangible book value per share
—
—
Working capital per share
—
—
Book value per share
—
—
Noticias
XTL Biopharmaceuticals recibe aviso de exclusión del Nasdaq
XTL Biopharmaceuticals recibe aviso de exclusión de Nasdaq
XTL Biopharmaceuticals faces Nasdaq delisting notice
Las acciones de XTL Biopharmaceuticals caen tras aviso de exclusión del Nasdaq
Acciones de XTL Biopharmaceuticals caen tras aviso de exclusión de Nasdaq
XTL Biopharmaceuticals stock falls on Nasdaq delisting notice
Los accionistas de XTL Biopharmaceuticals aprueban aumento de capital social y colocación privada
Accionistas de XTL Biopharmaceuticals aprueban aumento de capital y colocación
XTL Biopharmaceuticals shareholders approve share capital increase and private placement
La filial de XTL Biopharmaceuticals, Social Proxy, entra en liquidación tras orden judicial
Filial de XTL Biopharmaceuticals entra en liquidación por orden judicial
XTL Biopharmaceuticals subsidiary Social Proxy enters liquidation following court order